We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$316M
AUM Growth
-$29.1M
Cap. Flow
-$30M
Cap. Flow %
-9.48%
Top 10 Hldgs %
19.77%
Holding
567
New
205
Increased
77
Reduced
78
Closed
207

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$8.43M
2
FDX icon
FedEx
FDX
+$7.9M
3
IBM icon
IBM
IBM
+$6.03M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$5.99M
5
T icon
AT&T
T
+$5.41M

Sector Composition

Rank Sector Weight
1 Technology 28.34%
2 Consumer Discretionary 18.04%
3 Communication Services 14.64%
4 Industrials 11.75%
5 Healthcare 6.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOD icon
276
Vodafone
VOD
$40.9B
$263K 0.08%
+17,625
New +$269K
BMO icon
277
Bank of Montreal
BMO
$121B
$261K 0.08%
2,422
-1,717
-41% -$185K
AVYA
278
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$259K 0.08%
+13,100
New +$258K
PHM icon
279
Pultegroup
PHM
$22.8B
$252K 0.08%
+4,400
New +$226K
GGB icon
280
Gerdau
GGB
$9.93B
$246K 0.08%
63,126
+13,608
+27% +$51.7K
JNJ icon
281
Johnson & Johnson
JNJ
$644B
$246K 0.08%
+1,436
New +$235K
CCS icon
282
Century Communities
CCS
$1.74B
$245K 0.08%
+3,000
New +$214K
ERIC icon
283
Ericsson
ERIC
$32.8B
$245K 0.08%
22,500
-25,000
-53% -$273K
GRMN
284
Garmin
GRMN
$53.8B
$245K 0.08%
+1,800
New +$260K
HES
285
DELISTED
Hess
HES
$245K 0.08%
+3,314
New +$269K
PUBM icon
286
PubMatic
PUBM
$764M
$245K 0.08%
7,200
-4,900
-40% -$160K
STOR
287
DELISTED
STORE Capital Corporation
STOR
$244K 0.08%
+7,100
New +$241K
LH icon
288
Labcorp
LH
$26.3B
$243K 0.08%
901
-1,194
-57% -$296K
MD icon
289
Pediatrix Medical
MD
$2.17B
$241K 0.08%
+8,850
New +$237K
ABEV icon
290
Ambev
ABEV
$46.6B
$240K 0.08%
+85,700
New +$246K
TIGR
291
UP Fintech Holding
TIGR
$847M
$236K 0.07%
48,000
+14,300
+42% +$100K
CHKP icon
292
Check Point Software Technologies
CHKP
$14.1B
$235K 0.07%
+2,017
New +$234K
RGEN icon
293
Repligen
RGEN
$9.86B
$235K 0.07%
+886
New +$239K
DNA icon
294
Ginkgo Bioworks
DNA
$471M
$234K 0.07%
+705
New +$335K
JLL icon
295
Jones Lang LaSalle
JLL
$15.7B
$234K 0.07%
+869
New +$224K
NWS icon
296
News Corp Class B
NWS
$18.1B
$232K 0.07%
+10,332
New +$237K
VIR icon
297
Vir Biotechnology
VIR
$1.77B
$232K 0.07%
+5,540
New +$217K
PLCE icon
298
Children's Place
PLCE
$42.3M
$230K 0.07%
2,900
-764
-21% -$67.2K
CARG icon
299
CarGurus
CARG
$3.12B
$227K 0.07%
+6,751
New +$237K
FLWS icon
300
1-800-Flowers.com
FLWS
$197M
$226K 0.07%
+9,652
New +$280K

Similar funds

Bayesian Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Bayesian Capital Management held 567 positions worth $316M, down 8.4% from $345M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Bayesian Capital Management withdrew a net $30M in Q4 2021, closing 207 positions and reducing 78 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $17.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Bayesian Capital Management opened a new position in Oracle worth $7.83M.

  • Bayesian Capital Management's largest Q4 2021 buy was Oracle: 89,800 shares worth $7.83M.
  • Bayesian Capital Management added most to FedEx in Q4 2021, an estimated $7.9M increase.
  • Bayesian Capital Management's biggest Q4 2021 reduction was Micron Technology, cutting an estimated $9.92M.
  • Bayesian Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2021, selling an estimated $17.5M.
  • Bayesian Capital Management's ten largest holdings make up 20% of its $316M portfolio in Q4 2021.
  • Bayesian Capital Management opened 205 new positions and closed 207 in Q4 2021.
  • Bayesian Capital Management's portfolio value fell 8.4% quarter-over-quarter to $316M.

Based on Bayesian Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.